RSM logo
Annals of Clinical Biochemistry

Home Current issue Browse archive Alerts About the journal Feedback
 
Ann Clin Biochem 2008;45:91-92
doi:10.1258/acb.2007.007079
© 2008 Association for Clinical Biochemistry

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dimeski, G.
Right arrow Articles by Carter, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Short Report

Extent of bilirubin interference with Beckman creatinine methods

Goce Dimeski , Brett McWhinney, Brock Jones, Rebecca Mason and Andrew Carter


Department of Chemical Pathology, Queensland Health Pathology Service (QHPS), Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Queensland 4102, Australia


Corresponding author: Goce Dimeski. Email: Goce_Dimeski{at}health.qld.gov.au


Background: The aim of the study was to determine the extent of bilirubin interference on two different Beckman–Coulter creatinine methods used on the CX5 PRO/DxC 600 and the DxC 800 systems, respectively.

Methods: The Beckman methods were compared with a high-performance liquid chromatography (HPLC) method using 104 patient samples with creatinine concentrations <133 µmol/L and bilirubin concentrations of between 30 and 802 µmol/L.

Results: The linear regression analysis calculations expressing the relationship between bilirubin concentration and the observed difference between the Beckman and HPLC creatinine methods are: DxC800 creatinine M (modular or cup) method: r2 0.217, slope –0.023 and intercept 6.43; and DxC600 method: r2 0.7324, slope –0.0882 and intercept 12.01.

Conclusions: There is significantly greater interference by bilirubin on the CX5 PRO/DxC 600 method, which can lead to inaccuracy in the calculation of the estimated glomerular filtration rate by the Modification of Diet in Renal Disease equation.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
C. M. Cobbaert, H. Baadenhuijsen, and C. W. Weykamp
Prime Time for Enzymatic Creatinine Methods in Pediatrics
Clin. Chem., March 1, 2009; 55(3): 549 - 558.
[Abstract] [Full Text] [PDF]



MDU Exam Doctor